table of content
1 Introduction to Research & Analysis Reports
1.1 Radioimmunotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Radioimmunotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Radioimmunotherapy Overall Market Size
2.1 Global Radioimmunotherapy Market Size: 2021 VS 2028
2.2 Global Radioimmunotherapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Radioimmunotherapy Players in Global Market
3.2 Top Global Radioimmunotherapy Companies Ranked by Revenue
3.3 Global Radioimmunotherapy Revenue by Companies
3.4 Top 3 and Top 5 Radioimmunotherapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Radioimmunotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Radioimmunotherapy Players in Global Market
3.6.1 List of Global Tier 1 Radioimmunotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Radioimmunotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Radioimmunotherapy Market Size Markets, 2021 & 2028
4.1.2 Non Hodgkin Lymphoma (NHL)
4.1.3 Follicular Lymphoma
4.1.4 Solid Tumors
4.1.5 Breast Cancer
4.1.6 Ovarian Cancer
4.1.7 Osteosarcoma
4.1.8 Neuroblastoma
4.1.9 Prostate Cancer
4.2 By Type - Global Radioimmunotherapy Revenue & Forecasts
4.2.1 By Type - Global Radioimmunotherapy Revenue, 2017-2022
4.2.2 By Type - Global Radioimmunotherapy Revenue, 2023-2028
4.2.3 By Type - Global Radioimmunotherapy Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Radioimmunotherapy Market Size, 2021 & 2028
5.1.2 Tumor Antigens
5.1.3 Radionuclides
5.1.4 Antibodies
5.2 By Application - Global Radioimmunotherapy Revenue & Forecasts
5.2.1 By Application - Global Radioimmunotherapy Revenue, 2017-2022
5.2.2 By Application - Global Radioimmunotherapy Revenue, 2023-2028
5.2.3 By Application - Global Radioimmunotherapy Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Radioimmunotherapy Market Size, 2021 & 2028
6.2 By Region - Global Radioimmunotherapy Revenue & Forecasts
6.2.1 By Region - Global Radioimmunotherapy Revenue, 2017-2022
6.2.2 By Region - Global Radioimmunotherapy Revenue, 2023-2028
6.2.3 By Region - Global Radioimmunotherapy Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Radioimmunotherapy Revenue, 2017-2028
6.3.2 US Radioimmunotherapy Market Size, 2017-2028
6.3.3 Canada Radioimmunotherapy Market Size, 2017-2028
6.3.4 Mexico Radioimmunotherapy Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Radioimmunotherapy Revenue, 2017-2028
6.4.2 Germany Radioimmunotherapy Market Size, 2017-2028
6.4.3 France Radioimmunotherapy Market Size, 2017-2028
6.4.4 U.K. Radioimmunotherapy Market Size, 2017-2028
6.4.5 Italy Radioimmunotherapy Market Size, 2017-2028
6.4.6 Russia Radioimmunotherapy Market Size, 2017-2028
6.4.7 Nordic Countries Radioimmunotherapy Market Size, 2017-2028
6.4.8 Benelux Radioimmunotherapy Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Radioimmunotherapy Revenue, 2017-2028
6.5.2 China Radioimmunotherapy Market Size, 2017-2028
6.5.3 Japan Radioimmunotherapy Market Size, 2017-2028
6.5.4 South Korea Radioimmunotherapy Market Size, 2017-2028
6.5.5 Southeast Asia Radioimmunotherapy Market Size, 2017-2028
6.5.6 India Radioimmunotherapy Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Radioimmunotherapy Revenue, 2017-2028
6.6.2 Brazil Radioimmunotherapy Market Size, 2017-2028
6.6.3 Argentina Radioimmunotherapy Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Radioimmunotherapy Revenue, 2017-2028
6.7.2 Turkey Radioimmunotherapy Market Size, 2017-2028
6.7.3 Israel Radioimmunotherapy Market Size, 2017-2028
6.7.4 Saudi Arabia Radioimmunotherapy Market Size, 2017-2028
6.7.5 UAE Radioimmunotherapy Market Size, 2017-2028
7 Players Profiles
7.1 Bayer Healthcare Pharmaceuticals
7.1.1 Bayer Healthcare Pharmaceuticals Corporate Summary
7.1.2 Bayer Healthcare Pharmaceuticals Business Overview
7.1.3 Bayer Healthcare Pharmaceuticals Radioimmunotherapy Major Product Offerings
7.1.4 Bayer Healthcare Pharmaceuticals Radioimmunotherapy Revenue in Global Market (2017-2022)
7.1.5 Bayer Healthcare Pharmaceuticals Key News
7.2 BioSynthema
7.2.1 BioSynthema Corporate Summary
7.2.2 BioSynthema Business Overview
7.2.3 BioSynthema Radioimmunotherapy Major Product Offerings
7.2.4 BioSynthema Radioimmunotherapy Revenue in Global Market (2017-2022)
7.2.5 BioSynthema Key News
7.3 Clarity Pharmaceuticals
7.3.1 Clarity Pharmaceuticals Corporate Summary
7.3.2 Clarity Pharmaceuticals Business Overview
7.3.3 Clarity Pharmaceuticals Radioimmunotherapy Major Product Offerings
7.3.4 Clarity Pharmaceuticals Radioimmunotherapy Revenue in Global Market (2017-2022)
7.3.5 Clarity Pharmaceuticals Key News
7.4 Curasight
7.4.1 Curasight Corporate Summary
7.4.2 Curasight Business Overview
7.4.3 Curasight Radioimmunotherapy Major Product Offerings
7.4.4 Curasight Radioimmunotherapy Revenue in Global Market (2017-2022)
7.4.5 Curasight Key News
7.5 Endocyte
7.5.1 Endocyte Corporate Summary
7.5.2 Endocyte Business Overview
7.5.3 Endocyte Radioimmunotherapy Major Product Offerings
7.5.4 Endocyte Radioimmunotherapy Revenue in Global Market (2017-2022)
7.5.5 Endocyte Key News
7.6 Immunomedics
7.6.1 Immunomedics Corporate Summary
7.6.2 Immunomedics Business Overview
7.6.3 Immunomedics Radioimmunotherapy Major Product Offerings
7.6.4 Immunomedics Radioimmunotherapy Revenue in Global Market (2017-2022)
7.6.5 Immunomedics Key News
7.7 Molecular Insight Pharmaceuticals
7.7.1 Molecular Insight Pharmaceuticals Corporate Summary
7.7.2 Molecular Insight Pharmaceuticals Business Overview
7.7.3 Molecular Insight Pharmaceuticals Radioimmunotherapy Major Product Offerings
7.7.4 Molecular Insight Pharmaceuticals Radioimmunotherapy Revenue in Global Market (2017-2022)
7.7.5 Molecular Insight Pharmaceuticals Key News
7.8 Nordic Nanovector
7.8.1 Nordic Nanovector Corporate Summary
7.8.2 Nordic Nanovector Business Overview
7.8.3 Nordic Nanovector Radioimmunotherapy Major Product Offerings
7.8.4 Nordic Nanovector Radioimmunotherapy Revenue in Global Market (2017-2022)
7.8.5 Nordic Nanovector Key News
7.9 PDL Biopharma
7.9.1 PDL Biopharma Corporate Summary
7.9.2 PDL Biopharma Business Overview
7.9.3 PDL Biopharma Radioimmunotherapy Major Product Offerings
7.9.4 PDL Biopharma Radioimmunotherapy Revenue in Global Market (2017-2022)
7.9.5 PDL Biopharma Key News
7.10 Philogen
7.10.1 Philogen Corporate Summary
7.10.2 Philogen Business Overview
7.10.3 Philogen Radioimmunotherapy Major Product Offerings
7.10.4 Philogen Radioimmunotherapy Revenue in Global Market (2017-2022)
7.10.5 Philogen Key News
7.11 RadioMedix
7.11.1 RadioMedix Corporate Summary
7.11.2 RadioMedix Business Overview
7.11.3 RadioMedix Radioimmunotherapy Major Product Offerings
7.11.4 RadioMedix Radioimmunotherapy Revenue in Global Market (2017-2022)
7.11.5 RadioMedix Key News
7.12 Stella Pharma
7.12.1 Stella Pharma Corporate Summary
7.12.2 Stella Pharma Business Overview
7.12.3 Stella Pharma Radioimmunotherapy Major Product Offerings
7.12.4 Stella Pharma Radioimmunotherapy Revenue in Global Market (2017-2022)
7.12.5 Stella Pharma Key News
7.13 Telix Pharmaceuticals
7.13.1 Telix Pharmaceuticals Corporate Summary
7.13.2 Telix Pharmaceuticals Business Overview
7.13.3 Telix Pharmaceuticals Radioimmunotherapy Major Product Offerings
7.13.4 Telix Pharmaceuticals Radioimmunotherapy Revenue in Global Market (2017-2022)
7.13.5 Telix Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
